| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 4.1e-05 | 1 |